Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.

New laws will address e-vaporisers and etomidate, a dangerous anaesthetic agent found in Kpods, now a Class C drug under the Misuse of Drugs Act. Amendments to laws will be tabled in Parliament in the ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis. A new drug being ...

For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.

WASHINGTON – President Donald Trump signed an executive order Dec. 18 to federally classify marijuana as a less dangerous substance, the biggest change for the drug since 1970 and an opportunity for ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients. By Jan Hoffman President Trump on Thursday ordered cannabis to ...

A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...

Nov 4 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences (BX.N), opens new tab for $700 million to ...

Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of the Atlantic. Nitazenes were first synthesized in the 1950s by CIBA ...

The first record of chemotherapy to treat cancer came from Yale University in the 1940s. Researchers there realized that the "leukopenic" properties of mustard gas — that is, its ability to destroy ...

In 22.2% of trials, there was a survival benefit with the next-in-class agent. Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head ...